Research and Development
You can keep up to date with the research studies we are involved with via the research section on the BMG website and also, via our dedicated social media pages on Facebook and Twitter.
Please do get in touch with any queries or for further information about any of the studies we are currently running via firstname.lastname@example.org
The Valneva vaccine study
URGENT CALL: FOR COVID-19 VACCINE TRIAL PARTICIPANTS- AGED 30 OR OVER
The Valneva vaccine study is now open and will recruit those yet to have the COVID-19 jab. Manufactured in Livingston, if shownto be safe and effective, up to 100 miullion doses of the Valneva vaccine have been secured.
This vaccine study is taking part at two sites within the North West Coast region, The NIHR Patient Recruitment Centre at Blackpoool University Hospitals NHS Foundation Trust and the Halton Hospital at Warrington and Halton Hospitals NHS Trust.
The study now urgently requires those aged 30 or over to be enrolled into the study. Please send the link below to colleagues, friends and family.
This link contains information on what to expect if you take part in the study, who is eligible, where it is taking place and a screening questionnaire.
Thank you for your support.
Royal College of General Practitioners (RCGP) & Research & Surveillance Centre (RSC) – VIROLOGY SURVEILLANCE SCHEME
The Royal College of General Practitioners & Research and Surveillance Centre (RSC) provides clinical surveillance data and collects virological specimens from a representative national sample of general practices.
Its role is primarily to confirm cases of influenza, but also to look at the impact of other diseases, and to characterise more vulnerable populations. The RSC also supports the evaluation of vaccine effectiveness.
BMG are taking part in the general virological surveillance scheme which, continues to be a very important part of national surveillance. The scheme is a programme to measure the effectiveness of the influenza vaccination and is also, used for surveillance of respiratory viruses, including COVID-19, throughout the winter.
The burden of influenza during winter months and now the COVID-19 pandemic on the National Health Service is significant. COVID-19 surveillance is vital for public health surveillance. It enables us to monitor the spread of the virus over time, across age groups and regions in a nationally representative population. This type of surveillance is essential for estimating the burden of disease and informs modelling of the progression of the pandemic in England.
Why am I being offered a swab?
You may be offered a swab if your GP or clinical practitioner suspects you may be suffering or have recently suffered from Flu, COVID-19 or a similar respiratory illness. By providing this swab, you are enabling public health bodies to make crucial public health decisions.
What happens now?
The samples which you provide will be sent to PHE laboratory at Colindale to be tested for various respiratory illnesses including COVID-29, Influenza and Respiratory Syncytial Virus.
For more information about the surveillance scheme, accessing your swab results and data protection please read through the patient information sheet here: Virology Surveillance
If you have further enquiries regarding the Oxford RCGP research and Surveillance Centre- PHE virology surveillance scheme please contact the BMG research Team. Alternatively if you require further details you can contact the RCGP team by emailing email@example.com
RCGP & RSC Serology Surveillance for COVID-19
Bay Medical Group is taking part in the RCGP & RSC serology surveillance for COVID-19. We are collecting blood samples to look at the background immunity of the population to COVID-19. COVID-19 is a highly infectious disease and we are still learning about how it spreads and its effect on humans. analysing the blood samples will help us better understand the virus. If you attend an appointment for a prescheduled blood test you may be asked for an extra sample of blood, it is entirely voluntary and you do not have to take part.
Understanding of antibody response to COVID-19 is in its early stages and there is currently very little experience regarding use of antibody tests. As this virus is new, there is not enough information about what levels of antibodies would mean adequate protection. The results from the lab will not provide any information on whether you are protected from COVID-19 or not. Hence it is not possible to give either antibody result or interpretation of antibody result for COVID-19 to practices or patients.
Further information here PIS Serology Serveillance
PRINCIPLE STUDY- Urgent Public Health Study
Bay Medical Group is supporting vital COVID 19 research. As part of this, we are helping to carry out a national priority research study called PRINCIPLE.
If you have symptoms of COVID 19, are aged 65 or over, OR are aged 50-64 and have an existing health condition, you may be eligible to join this important study.
If you'd like to discuss taking part in PRINCIPLE, please contact us.
Please see www.phctrials.ox.ac.uk/principle-trial for full details of this study.
If you'd like to know more about COVID 19 research and how you can contribute, please visit the Be Part of Research site, www.bepartofresearch.nihr.ac.uk, which is run by the National Institute for Health Research.
Or watch the youtube clip
Virus Watch Study
The Virus Watch Study is an Urgent Public Health Study they are looking for households to join and help them understand how Covid-19 acts and spreads. Follow the link below to register or click here https://ucl-virus-watch.net/
Virus Watch aims to identify how the virus spreads, and, how to stop it and prevent a second wave. To achieve this we need help from people in every community in the UK – from you and your family. Join thousands of households already taking part in our Virus Watch study and together we can help beat the virus.
You and your household can help us beat a second wave of Covid-19 by telling us each week whether you are all well or have any symptoms. It takes 10 mins per household member to sign up.
Chosen participants will receive antibody tests to see if they have had COVID-19 and might now have resistance against the virus. As we gather the results from our study you’ll be able to see them on our website. In this way, your family will have the very latest COVID-19 information.
Register for the study here
If you have registered for the study in the last few hours please ignore this email as our system may not have updated to reflect that yet.
Bay Medical are happy to be supporting this important study The Genetic Links to Anxiety and Depression (GLAD) Study is for people 16yrs+ who have experienced clinical anxiety and/or depression during their life.